CUREVAC NV (5CV.DE) Stock Income Statement
FRA:5CV - Deutsche Boerse Ag - NL0015436031 - Common Stock - Currency: EUR
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 543.28M | 53.76M | 67.40M | 103.00M | 48.90M | |||
| Cost Of Goods | 157.94M | 116.28M | 159.00M | 238.20M | 14.20M | |||
| Gross Profit | 385.34M | -62.52M | -91.60M | -135.20M | 34.70M | |||
| Operating Expenses | 253.13M | 207.16M | 133.40M | 343.50M | 144.50M | |||
| Research and Development | 130.55M | 107.19M | 53.90M | 811.60M | 111.20M | |||
| Selling, General, and Administrative Expenses | 72.52M | 81.79M | 95.30M | 93.20M | 48.20M | |||
| Operating Income | 132.21M | -269.69M | -225.00M | -478.70M | -109.80M | |||
| Interest Income/Expense | 9.53M | 14.24M | 300.00K | -200.00K | -20.00M | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | -24.15M | |||
| Non Recurring Items | 1.22M | -4.52M | -24.50M | 66.40M | N/A | |||
| Income Before Taxes | 142.96M | -259.97M | -249.20M | -412.50M | -129.80M | |||
| Income Tax | 34.66M | 198.00K | -100.00K | -800.00K | -700.00K | |||
| Net Income | 108.29M | -260.17M | -249.00M | -411.70M | -129.10M | |||
| EBITDA | 152.70M | -246.30M | -201.30M | -463.00M | -99.10M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.48 | -1.18 | -1.28 | -2.20 | -0.72 | |||
| Non GAAP EPS | 0.48 | -1.18 | -1.24 | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 70.93% | -116.30% | -135.91% | -131.26% | 70.96% | |||
| Profit Margin | 19.93% | -483.96% | -369.44% | -399.71% | -264.01% | |||
| Operating Profit Margin | 24.34% | -501.67% | -333.83% | -464.76% | -224.54% | |||
All data in EUR